Literature DB >> 18809466

Establishment of human cell lines showing circadian rhythms of bioluminescence.

Aki Yoshikawa1, Hiroko Shimada, Kahori Numazawa, Tsukasa Sasaki, Masaaki Ikeda, Minae Kawashima, Nobumasa Kato, Katsushi Tokunaga, Takashi Ebisawa.   

Abstract

We have established human retinal pigment epithelial cell lines stably expressing the luciferase gene, driven by the human Bmal1 promoter, to obtain human-derived cells that show circadian rhythms of bioluminescence after dexamethasone treatment. The average circadian period of bioluminescence for the obtained clones was 24.07+/-0.48 h. Lithium (10 mM) in the medium significantly lengthened the circadian period of bioluminescence, which is consistent with previous reports, while 2 mM or 5 mM lithium had no effect. This is the first report on the establishment of human-derived cell lines that proliferate infinitely and show circadian rhythms of bioluminescence, and also the first to investigate the effects of low-dose lithium on the circadian rhythms of human-derived cells in vitro. The established cells will be useful for various in vitro studies of human circadian rhythms and for the development of new therapies for human disorders related to circadian rhythm disturbances.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18809466     DOI: 10.1016/j.neulet.2008.08.091

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  Introduction of tau mutation into cultured Rat1-R12 cells by gene targeting, using recombinant adeno-associated virus vector.

Authors:  Hiroko Shimada; Kahori Numazawa; Tsukasa Sasaki; Nobumasa Kato; Takashi Ebisawa
Journal:  Cell Mol Neurobiol       Date:  2009-03-21       Impact factor: 5.046

2.  Analysis of the molecular pathophysiology of sleep disorders relevant to a disturbed biological clock.

Authors:  Takashi Ebisawa
Journal:  Mol Genet Genomics       Date:  2013-04-02       Impact factor: 3.291

3.  Circadian regulation of the PERIOD 2::LUCIFERASE bioluminescence rhythm in the mouse retinal pigment epithelium-choroid.

Authors:  Kenkichi Baba; Anamika Sengupta; Manfredi Tosini; Susana Contreras-Alcantara; Gianluca Tosini
Journal:  Mol Vis       Date:  2010-12-07       Impact factor: 2.367

4.  Serum Amyloid A3 Gene Expression in Adipocytes is an Indicator of the Interaction with Macrophages.

Authors:  Yohei Sanada; Takafumi Yamamoto; Rika Satake; Akiko Yamashita; Sumire Kanai; Norihisa Kato; Fons Aj van de Loo; Fusanori Nishimura; Philipp E Scherer; Noriyuki Yanaka
Journal:  Sci Rep       Date:  2016-12-08       Impact factor: 4.379

5.  Regulation of molecular clock oscillations and phagocytic activity via muscarinic Ca2+ signaling in human retinal pigment epithelial cells.

Authors:  Rina Ikarashi; Honami Akechi; Yuzuki Kanda; Alsawaf Ahmad; Kouhei Takeuchi; Eri Morioka; Takashi Sugiyama; Takashi Ebisawa; Masaaki Ikeda; Masayuki Ikeda
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

6.  In vivo evaluation of the effect of lithium on peripheral circadian clocks by real-time monitoring of clock gene expression in near-freely moving mice.

Authors:  Yuka Sawai; Takezo Okamoto; Yugo Muranaka; Rino Nakamura; Ritsuko Matsumura; Koichi Node; Makoto Akashi
Journal:  Sci Rep       Date:  2019-07-29       Impact factor: 4.379

Review 7.  Circadian Regulation of Retinal Pigment Epithelium Function.

Authors:  Kenkichi Baba; Varunika Goyal; Gianluca Tosini
Journal:  Int J Mol Sci       Date:  2022-02-28       Impact factor: 5.923

Review 8.  Implications and limitations of cellular reprogramming for psychiatric drug development.

Authors:  Brian T D Tobe; Michael G Brandel; Jeffrey S Nye; Evan Y Snyder
Journal:  Exp Mol Med       Date:  2013-11-15       Impact factor: 8.718

9.  Histamine Regulates Molecular Clock Oscillations in Human Retinal Pigment Epithelial Cells via H1 Receptors.

Authors:  Eri Morioka; Yuzuki Kanda; Hayato Koizumi; Tsubasa Miyamoto; Masayuki Ikeda
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-19       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.